NCT06127251Completed
Active You: Walk, Dance, and Tone Your Abs to Reduce Your Risk of Diabetes
A Pilot Randomized Clinical Trial of Walking, Dance, and Abdominal Core Workouts to Improve Adipocytokines Among Insufficiently Active Adults With Obesity
Source: ClinicalTrials.gov · Last updated 22 Jul 2026
Brief summary (registry, in English)
The phenomenon of physical activity (PA) avoidance in obesity has been detailed in the literature, but there is a lack of programs designed to address the root causes. In addition to common PA barriers such as lack of time, individuals with obesity face weight-related impediments, including stigma, shame, poor fitness, and low exercise self-efficacy, which reduce their engagement in PA. These impediments have been observed in white and minoritized populations. Numerous studies have suggested that individuals with obesity prefer activities that are enjoyable, less exhausting, and conveniently available in settings where they are not exposed to stigma. The studies also point to a need for programs that focus on the general health benefits of PA rather than weight loss, which although desirable, can be elusive. Unmet weight loss expectations contribute to high dropout rates and non-adherence to the prescribed PA regimen among those with obesity. This is particularly consequential for minoritized populations including African Americans who tend to lose less weight in lifestyle interventions but achieve significant improvements in many cardiometabolic outcomes. In this proposal, investigators present PA as a buffer against the deleterious effects of obesity, agnostic of weight loss status. The Physical Activity for The Heart (PATH) program was intentionally designed to provide vicarious experiences for diverse individuals with obesity, by featuring their peers in body size, fitness level, and age engaging in PA. The impact of the PATH intervention on these biomarkers will provide important insights into the mechanisms via which a combination of popular PA modalities improves cardiometabolic outcomes in the context of obesity.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 54 (actual)
- First submitted
- 7 Nov 2023
- Start date
- 11 Apr 2024
- Primary completion date
- 18 May 2025
- Lead sponsor
- Emory University
- Diseases
- Obesity
- NCT number
- NCT06127251
What you commit to
- Study type: Interventional
- Participants enrolled: 54
- From 11 Apr 2024 to the primary completion date, 18 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- involvement in litigation related to a health issue, or a condition that requires supervised PA (e.g., stroke).
- Individuals with a history of cerebrovascular disease (CVD), type 2 diabetes (T2D),
Lab values
- any affirmative response to any question in the Physical Activity Readiness Questionnaire (PAR-Q) will require primary care physician (PCP) clearance before enrollment.
Other
- pregnancy/intention to become pregnant within 12 weeks,
Who the study is looking for
- age ≥18 years, body mass index (BMI) ≥30kg/m2,
- regular access to the Internet,
- self-monitoring of PA via waist worn Actigraph during run-in (≥4 days with ≥10hrs wear time),
- self-reported non-adherence to PA Guidelines \[\<150 min of moderate to vigorous physical activities (MVPA/wk)\].
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Emory University Coordinator of this site? Confirm its status | Atlanta | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.